Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
The tumour suppressor p33ING1 does not regulate migration and angiogenesis in melanoma cells
1Division of Dermatology, Department of Medicine, University of British Columbia, and Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia V6H 3Z6, Canada.
Abstract:
The tumour suppressor ING1 shares many biological functions with p53, such as cell cycle arrest, DNA repair, apoptosis, and chemosensitivity. Since p53 inhibits invasion and angiogenesis of melanoma cells, we sought to investigate if p33ING1 (one of ING1 isoforms) is also involved in these biological processes. We first overexpressed p33ING1 in melanoma cells and assessed the protein levels in MMP-1, MMP-2, and MMP-9. Results from Western blot analysis showed no significant difference in these matrix metalloproteinase levels between cells transfected with vector, p33ING1, and antisense p33ING1. Wound healing assay was performed to examine if p33ING1 plays a role in migration and invasion. Results showed that there was no difference between vector, p33ING1, and antisense p33ING1 groups in melanoma cell migration across the wound. Western blot analysis also indicated that there is no difference in the levels of proteins which are directly involved in angiogenesis, such as VEGF, Flt-1, and Flk-1, between cells transfected with vector, p33ING1, and antisense p33ING1. Furthermore, functional studies indicated that cultured medium derived from p33ING1-transfected melanoma cells did not stimulate the growth of HUVEC cells, compared to controls, providing support to the lack of functional role of p33ING1 in angiogenesis. In conclusion, we demonstrate in vitro that p33ING1, unlike p53, does not play a role in angiogenesis and migration in melanoma cells.
Insights
The tumor suppressor p33ING1 does not affect melanoma cell invasion or blood vessel formation (angiogenesis). Unlike p53, p33ING1 does not inhibit melanoma cell migration or angiogenesis in vitro.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The tumor suppressor ING1 shares functions with p53, including cell cycle arrest and apoptosis.
- p53 is known to inhibit melanoma cell invasion and angiogenesis.
- The role of ING1 isoforms, specifically p33ING1, in these processes remains unclear.
Purpose of the Study:
- To investigate the role of p33ING1 in melanoma cell invasion and angiogenesis.
- To determine if p33ING1 influences matrix metalloproteinase (MMP) levels and cell migration.
- To assess the impact of p33ING1 on angiogenesis-related factors and endothelial cell proliferation.
Main Methods:
- Overexpression of p33ING1 in melanoma cells.
- Western blot analysis for MMPs (MMP-1, MMP-2, MMP-9) and angiogenesis factors (VEGF, Flt-1, Flk-1).
- Wound healing assays for cell migration and in vitro angiogenesis assays using HUVEC cells.
Main Results:
- p33ING1 overexpression did not alter MMP levels or melanoma cell migration.
- No significant changes were observed in angiogenesis-related protein levels (VEGF, Flt-1, Flk-1).
- Conditioned media from p33ING1-expressing cells did not enhance HUVEC proliferation, indicating no pro-angiogenic effect.
Conclusions:
- In vitro studies show that p33ING1 does not play a role in the migration or angiogenesis of melanoma cells.
- These findings differentiate p33ING1 from p53 regarding their functions in melanoma progression.
- p33ING1 does not appear to regulate key pathways involved in melanoma invasion and vascularization.
Related Concept Videos
Abnormal Proliferation
Regulation of Angiogenesis and Blood Supply
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity

